EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 123 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.39 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $67,700,000 | +25.6% | 853,285 | +10.8% | 0.01% | +9.1% |
| Q3 2016 | $53,891,000 | +237.4% | 769,869 | +87.0% | 0.01% | +175.0% |
| Q2 2016 | $15,971,000 | -3.6% | 411,735 | +0.6% | 0.00% | 0.0% |
| Q1 2016 | $16,574,000 | -52.5% | 409,234 | +4.1% | 0.00% | -50.0% |
| Q4 2015 | $34,856,000 | +130.2% | 393,097 | +92.2% | 0.01% | +100.0% |
| Q3 2015 | $15,139,000 | -8.9% | 204,499 | -0.5% | 0.00% | 0.0% |
| Q2 2015 | $16,615,000 | +4366.4% | 205,479 | +2215.0% | 0.00% | – |
| Q1 2015 | $372,000 | +644.0% | 8,876 | +174.7% | 0.00% | – |
| Q4 2014 | $50,000 | -95.0% | 3,231 | -95.9% | 0.00% | – |
| Q1 2014 | $1,003,000 | – | 78,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |